Voriconazole Vs. Itraconazole for Antifungal Prophylaxis in Patients with GVHD: A Randomized Trial

Voriconazole Vs. Itraconazole for Antifungal Prophylaxis in Patients with GVHD: A Randomized Trial Yoshiki Hayashi , Yoshinobu Kanda , Hirohisa Nakamae , Heiwa Kanamori , Kazuteru Ohashi , Michihiro Hidaka , Shingo Yano , Kazuo Hatanaka , Akio Kohno , Yukiyoshi Moriuchi , Hiroatsu Ago , Takuya Yamashita , Tohru Takata , Minoru Yoshida , Masayuki Hino , Takuhiro Yamaguchi , Takahiro Fukuda . 1 Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan; 3 Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 4 Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan; 5 Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; 6 Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan; Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan; 8 Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan; 9 Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan; 10 Department of Hematology, Sasebo City General Hospital, Sasebo, Japan; Department of Hematology and Oncology, Shimane Prefectural Central Hospital, Shimane, Japan; 12 Department of Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 13 Department of Infection Control, Fukuoka University Hospital, Fukuoka, Japan; 14 Fourth Department of Internal Medicine, Teikyo University School of Medicine, Kawasaki, Japan; 15 Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan